Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vijay L. Mehra"'
Autor:
Fatima Laher, Zoe Moodie, Kristen W Cohen, Nicole Grunenberg, Linda-Gail Bekker, Mary Allen, Nicole Frahm, Nicole L Yates, Lynn Morris, Mookho Malahleha, Kathryn Mngadi, Brodie Daniels, Craig Innes, Kevin Saunders, Shannon Grant, Chenchen Yu, Peter B Gilbert, Sanjay Phogat, Carlos A DiazGranados, Marguerite Koutsoukos, Olivier Van Der Meeren, Carter Bentley, Nonhlanhla N Mkhize, Michael N Pensiero, Vijay L Mehra, James G Kublin, Lawrence Corey, David C Montefiori, Glenda E Gray, M Juliana McElrath, Georgia D Tomaras
Publikováno v:
PLoS Medicine, Vol 17, Iss 2, p e1003038 (2020)
BackgroundHVTN 100 evaluated the safety and immunogenicity of an HIV subtype C pox-protein vaccine regimen, investigating a 12-month booster to extend vaccine-induced immune responses.Methods and findingsA phase 1-2 randomized double-blind placebo-co
Externí odkaz:
https://doaj.org/article/a8f5e1efa20e4dca897e71b9fcfdaef2
Autor:
Xiaoying Shen, Fatima Laher, Zoe Moodie, Rachel L. Spreng, Georgia D. Tomaras, Sanjay Phogat, Vijay L. Mehra, Michael Pensiero, Susan W. Barnett, Nicole Grunenberg, M. Juliana McElrath, Peter B. Gilbert, Mary Allen, Glenda Gray, Nicole L. Yates, Linda-Gail Bekker, Lawrence Corey, Olivier Van Der Meeren, Arthur S. McMillan, Ying Huang
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
In the RV144 trial, vaccine-induced V1V2 IgG correlated with decreased HIV-1 risk. We investigated circulating antibody specificities in two phase 1 poxvirus prime-protein boost clinical trials conducted in South Africa: HVTN 097 (subtype B/E) and HV
Autor:
Kathryn Therese. Mngadi, Vijay L. Mehra, Kristen W. Cohen, Glenda Gray, Shannon Grant, Zoe Moodie, Brodie Daniels, Marguerite Koutsoukos, Sanjay Phogat, Peter B. Gilbert, M. Juliana McElrath, Nonhlanhla N. Mkhize, Chenchen Yu, Georgia D. Tomaras, Olivier Van Der Meeren, Linda-Gail Bekker, James G. Kublin, Nicole Frahm, Carlos A. DiazGranados, Mary Allen, Lawrence Corey, Fatima Laher, Carter Bentley, Mookho Malahleha, Michael Pensiero, Lynn Morris, Kevin O. Saunders, Nicole L. Yates, Nicole Grunenberg, David C. Montefiori, Craig Innes
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 2, p e1003038 (2020)
PLoS Medicine, Vol 17, Iss 2, p e1003038 (2020)
Background HVTN 100 evaluated the safety and immunogenicity of an HIV subtype C pox-protein vaccine regimen, investigating a 12-month booster to extend vaccine-induced immune responses. Methods and findings A phase 1–2 randomized double-blind place
Autor:
Rebecca L. Sheets, Vijaya Rangavajhula, Jeffrey K. Pullen, Stuart Z. Shapiro, Vijay L. Mehra, Chris Butler, Michael Pensiero
Publikováno v:
Vaccine. 33:1757-1766
The Division of AIDS Vaccine Research Program funds the discovery and development of HIV/AIDS vaccine candidates. Basic researchers, having discovered a potential vaccine in the laboratory, next want to take that candidate into the clinic to test the
Publikováno v:
Vaccine. 28:4689-4694
Although 80% of HIV infections occur through mucosal routes and vaccine strategies need to be designed for inducing protective immune responses at the site of the viral entry, it has proven to be very challenging to measure these responses. A 2-day w
Autor:
Jean-François Delfraissy, Livia Pedroza-Martins, Marc Girard, Marco Schito, Bonnie J. Mathieson, James Bradac, Betty Dodet, Vijay L. Mehra, Geetha P. Bansal
Publikováno v:
Vaccine
In October 2007, a joint ANRS-NIH workshop was held on "Mucosal immunity and HIV/AIDS vaccines" in Veyrier-du-Lac, France. Goal of the meeting was to discuss recent developments in the understanding of viral entry and dissemination at mucosal surface